Theravance Biopharma (TBPH) Other financing activities (2014 - 2026)
Theravance Biopharma (TBPH) reported Other financing activities of $5.8 million for Q1 2026, up 565.68% year-over-year from $874000.0 in Q1 2025, and up 193.99% quarter-over-quarter from $2.0 million in Q4 2025.
Theravance Biopharma (TBPH) Other financing activities (2014 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has 12 years of Other financing activities data on file, last reported at $5.8 million in Q1 2026.
- Other financing activities for Q1 2026 came in at $5.8 million, up 565.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (up 296.73% YoY), and the FY2025 annual result was $4.0 million, up 51.71% from the prior year.
- Other financing activities improved to $5.8 million in Q1 2026 per TBPH's latest filing, from $2.0 million in the prior quarter.
- Over five years, Other financing activities peaked at $23.6 million in Q4 2022 and troughed at $347000.0 in Q2 2022.
- A 5-year average of $2.4 million and a median of $662000.0 in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2023: Other financing activities jumped 5095.38% in 2022, then slumped 97.81% in 2023.
- A 5-year view of Other financing activities shows it stood at $23.6 million in 2022, then tumbled by 97.81% to $518000.0 in 2023, then grew by 1.93% to $528000.0 in 2024, then jumped by 274.81% to $2.0 million in 2025, then surged by 193.99% to $5.8 million in 2026.
- Business Quant data shows TBPH's Other financing activities at $5.8 million in Q1 2026, $2.0 million in Q4 2025, and $678000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Theravance Biopharma | 846.10 Mn | 451.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.82 Mn |
| Mar 31, 2026 | 5.82 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 678,000.00 |
| Sep 30, 2025 | 678,000.00 |
| Jun 30, 2025 | 503,000.00 |
| Jun 30, 2025 | 503,000.00 |
| Mar 31, 2025 | 874,000.00 |
| Mar 31, 2025 | 874,000.00 |
| Dec 31, 2024 | 528,000.00 |
| Dec 31, 2024 | 528,000.00 |
| Sep 30, 2024 | 397,000.00 |
| Sep 30, 2024 | 397,000.00 |
| Jun 30, 2024 | 464,000.00 |
| Jun 30, 2024 | 464,000.00 |
| Mar 31, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 518,000.00 |
| Dec 31, 2023 | 518,000.00 |